Closed
SectorHealthcare
7.05 4.75
24h
Min
6.55
Max
7.23
Income | 8.4M -51M |
---|---|
Sales | -3M 21M |
EPS | -1.01 |
Profit margin | -241.284 |
Employees | 353 |
EBITDA | 17M -38M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +391.12% upside |
Next Earnings | 7 May 2025 |
---|
Market Cap | 94M 392M |
---|---|
Previous open | 2.3 |
Previous close | 7.05 |
By Acuity
34%
66%
103 / 386 Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 33.2 USD 391.12%
High 50 USD
Low 14 USD
Based on 11 Wall Street analysts offering 12 month price targets forREGENXBIO Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$